Literature DB >> 22024040

The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.

Bin Wang1, Jin-Yu Liu, Dan Yang, Luo-Luo Yang, De-Xia Kong, Xiang-Wei Meng.   

Abstract

BACKGROUND/AIMS: Abnormalities in cell cycle regulation are reported to be strongly associated with tumorigenesis and progression of tumors. Wnt/β-catenin signaling pathway and cell cycle play key roles during the genesis and development of hepatocellular carcinoma (HCC). Current studies indicated that expressions of cyclin A, E and D1 were affected after silencing of β-catenin gene in HCC, but it is unclear if other cyclins are affected.
METHODOLOGY: To determine the relation, small interference RNA (siRNA) against β-catenin was transfected into HCC cell lines HepG2 and SMMC-7721, and cell cycle and cyclin B1 and cyclin C protein expression were detected.
RESULTS: Cell cycle was arrested in G0/G1 at 72h after transfection and the cell cycle began to transfer from G0/G1 to G2/M through S and had a trend to revert at 96h. In addition, β-catenin protein expression was decreased at both 72 and 96h, although the level was slightly higher at 96h than that at 72h. However, cyclin B1 expression decreased at 72h and increased at 96h, cyclin C expression increased at 72h and decreased at 96h.
CONCLUSIONS: These findings suggest that silencing β-catenin gene may induce the changes of cell cycle and cyclin B1 and cyclin C protein expression. Wnt/β-catenin signaling pathway probably takes part in the genesis and development of HCC through regulating cell cycle and the expression of cyclin B1 and cyclin C.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22024040     DOI: 10.5754/hge11534

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

1.  Overexpression of FABP3 inhibits human bone marrow derived mesenchymal stem cell proliferation but enhances their survival in hypoxia.

Authors:  Suna Wang; Yifu Zhou; Oleg Andreyev; Robert F Hoyt; Avneesh Singh; Timothy Hunt; Keith A Horvath
Journal:  Exp Cell Res       Date:  2014-02-27       Impact factor: 3.905

Review 2.  Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.

Authors:  Valery Vilchez; Lilia Turcios; Francesc Marti; Roberto Gedaly
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

3.  Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model.

Authors:  Zhi Yang; Qianzhen Zhang; Ke Xu; Juanjuan Shan; Junjie Shen; Limei Liu; Yanmin Xu; Feng Xia; Ping Bie; Xia Zhang; Youhong Cui; Xiu-Wu Bian; Cheng Qian
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

4.  The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma.

Authors:  Weiwei Luo; Minjun Liao; Yan Liao; Xinhuang Chen; Chunyan Huang; Jiyuan Fan; Weijia Liao
Journal:  World J Surg Oncol       Date:  2018-02-21       Impact factor: 2.754

5.  Genistein inhibits human papillary thyroid cancer cell detachment, invasion and metastasis.

Authors:  Chunyan Zhang; Bin Lv; Cuihua Yi; Xiujie Cui; Shaofeng Sui; Xueen Li; Mei Qi; Chunyan Hao; Bo Han; Zhiyan Liu
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

Review 6.  HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models.

Authors:  Joseph Torresi; Bang Manh Tran; Dale Christiansen; Linda Earnest-Silveira; Renate Hilda Marianne Schwab; Elizabeth Vincan
Journal:  BMC Cancer       Date:  2019-07-18       Impact factor: 4.430

Review 7.  Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents.

Authors:  Federico Selvaggi; Teresa Catalano; Roberto Cotellese; Gitana Maria Aceto
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

8.  Construction of a competing endogenous RNA network to analyse glucose-6-phosphate dehydrogenase dysregulation in hepatocellular carcinoma.

Authors:  Pengyu Wang; Xitong Yang; Dan Liu; Yunhui Yang; Yuanyuan Zhang; Guangming Wang
Journal:  Biosci Rep       Date:  2022-06-30       Impact factor: 3.976

9.  Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.

Authors:  Min Wu; Zhaobo Liu; Aiying Zhang; Ning Li
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

10.  Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.

Authors:  Meng Wang; Licheng Wang; Shusheng Wu; Dongsheng Zhou; Xianming Wang
Journal:  Int J Genomics       Date:  2019-11-22       Impact factor: 2.326

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.